Market Definition
Cell culture is the process of growing & maintaining cells outside their natural environment, typically within a laboratory setting. It involves the isolation & propagation of cells derived from various sources like animal tissues, plants, or microorganisms in a controlled environment. The primary objective of cell culture is to provide an artificial environment that can support cell survival, proliferation, & maintenance of specific cellular functions.
Market Insights & Analysis: Global Cell Culture Market (2023-28)
The Global Cell Culture Market is projected to grow at around 11.4% CAGR during the forecast period, i.e., 2023-28. The growth of the market would be propelled mainly by the accelerating demand for biopharmaceuticals to cater to the rising incidence of chronic disorders worldwide, advancements in cell culture technologies, and the mounting focus on regenerative medicine & stem cell research. Besides, massive investments in academics & research, the growing application of cell culture products in toxicology testing & drug development, and the emergence of personalized medicine & cell-based therapies are other prominent aspects expected to drive the market.
Cell culture plays a crucial role in the production of biologics like therapeutic proteins, monoclonal antibodies, & vaccines. The flourishing biopharmaceutical industry, on account of the rising incidence of chronic disorders and the aging population, is instigating the use of cell culture technologies for drug discovery, development, & manufacturing. The world is witnessing ongoing advances in cell culture technologies to enhance productivity, scalability, & reproducibility.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2018-21 |
| Base Year: 2022 | |
| Forecast Period: 2023-28 | |
| CAGR (2023-2028) | 11.4% |
| Regions Covered | North America: US, Canada, Mexico |
| Europe: Germany, The UK, France, Spain, Italy, Rest of Europe | |
| Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific | |
| South America: Brazil, Argentina, Rest of South America | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA | |
| Key Companies Profiled | Biospherix, Ltd., Bio-Techne Corporation, Promocell Gmbh, Eppendorf SE, Vwr International, LLC, Merck KGaA, Becton, Dickinson & Company, Thermo Fisher Scientific, Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Himedia Laboratories, Lonza Group Ltd., Cell Culture Company LLC, Other |
| Unit Denominations | USD Million/Billion |
Innovations like single-use bioreactors, automated systems, microcarrier-based cultures, and 3D cell culture systems have improved efficiency & flexibility in cell culture processes. These advancements are attracting massive investments in providing more effective & efficient solutions for cell culture applications.
Moreover, regenerative medicine and stem cell research hold immense potential for treating numerous diseases & injuries, and cell culture is a fundamental technique in these fields, i.e., facilitating the expansion & differentiation of stem cells for therapeutic applications. Hence, the mounting focus on regenerative medicine & stem cell research is amplifying the demand for cell culture products & services globally.
Furthermore, the rising number of cancer research projects worldwide, the widening scope of applications for gene therapies, and the burgeoning demand for cost-effective & highly efficient bioreactors, media, reagents, & sera for the production of high-yield cell lines are also expected to boost the Global Cell Culture Market through 2028.
Global Cell Culture Market Key Driver:
Ever-Increasing Demand for Biopharmaceuticals - In recent years, biopharmaceuticals, including recombinant proteins, monoclonal antibodies, vaccines, and cell-based therapies, have gained significant importance in modern healthcare. It owes mainly to the rising prevalence of chronic diseases worldwide, which include cancer, autoimmune disorders, and metabolic disorders, to which biopharmaceuticals offer targeted & effective treatment options. Since the production of these complex biotherapeutics requires cell culture techniques, their mounting demand worldwide to treat chronic diseases is projected to drive the Global Cell Culture Market during 2023-28.
Global Cell Culture Market Possible Restraint:
High Cost of Cell Culture Processes & Products - Establishing & maintaining a cell culture facility incurs massive investments in infrastructure, including specialized laboratories, cleanrooms, incubators, & bioreactors, among other equipment. Since the cost of setting up & operating such facilities can be substantial, it limits the entry of small & medium-sized enterprises into the industry. Besides, cell culture media, sera, & other consumables used in cell culture, coupled with the use of recombinant growth factors & defined media formulations, are also expensive. Hence, these high costs associated with cell culture products & processes are the major growth restraints for the Global Cell Culture Market.
Global Cell Culture Market (2023-28): Segmentation Analysis
The Global Cell Culture Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2023–2028 at the global, regional, and national levels. Based on the Product, and Application the market has been further classified as:
Based on Product:
Of them all, consumables, particularly media, dominate the Global Cell Culture Market. It owes to their customization, versatility, & standardization, the mounting demand for media products for various research & development applications, and the availability of numerous serum- & animal-component-free as well as customized media alternatives. These nutrient-rich solutions are crucial consumables in cell culture and are available in various formulations to meet the specific requirements of different cell types. They provide essential nutrients, growth factors, and hormones to support cell growth & proliferation in vitro. More & more specialized media for stem cell applications are being commercialized.
As cell culture techniques advance and new applications emerge, the demand for specialized & tailored cell culture media is likely to rise further in the future and, in turn, solidify their dominance in the market. Ongoing R&D activities to enhance media formulations, include advancements like chemically defined & animal component-free media, and address concerns related to reproducibility, standardization, & ethical considerations associated with the use of animal-derived components shall further fuel the importance of cell culture media and, consequently, stimulate the growth of the cell culture market in the coming years.
Based on Application:
Here, biopharmaceuticals held the largest market share in the previous few years. It owes mainly to the ever-increasing production & consumption of biopharmaceuticals, the mounting demand for non-conventional drugs, and the involvement of mammalian cell lines like the Chinese hamster ovary in the manufacturing of biopharmaceuticals.
Biopharmaceuticals like recombinant proteins, monoclonal antibodies, & therapeutic enzymes have become integral parts of modern healthcare. Since cell culture is crucial for the production of these complex biotherapeutics, the burgeoning demand for therapeutic proteins to treat various diseases, including cancer, autoimmune disorders, & genetic conditions, is driving the cell culture market.
Besides, the emergence of several grafting techniques & personalized treatment options in recent years, the ever-increasing prevalence of various chronic diseases, and the rising awareness among people of biopharmaceuticals are also aiding in the expansion of the biopharmaceutical application of cell culture systems and, in turn, spurring growth in the industry.
Global Cell Culture Market Regional Projection
Of all regions globally, North America dominates the Cell Culture Market with the largest share, and the same trend is likely during 2023-28. It owes to the region being at the forefront of technological advancements in cell culture techniques, the well-established biotechnology & pharmaceutical industries, and the strong presence of renowned academic & research institutions. Besides, the ever-growing demand for personalized medicine, vaccines, artificial organs, and biopharmaceuticals like stem cell & and gene therapies, coupled with massive investments in the advancement of biotechnology R&D, are other prominent aspects backing the regional market growth.
Over the years, North America, particularly the US, has become the global hub of drug R&D owing to substantial expenditure by both the government & private sector companies. With such a strong emphasis on R&D in the biotechnology & pharmaceutical industries, the region has witnessed technological advancements in cell culture techniques, including the development of advanced cell culture media, bioreactors, & automated systems.
Numerous companies in North America are engaged in drug discovery, development, & production and heavily rely on cell culture techniques for various purposes like screening potential drug candidates, producing therapeutic proteins, and conducting preclinical & clinical studies.
Moreover, the region also has a well-defined regulatory framework for the biotechnology & pharmaceutical industries, where regulatory bodies like the US FDA & Health Canada have established guidelines & quality standards for the use of cell culture in drug development, which, in turn, favors industry players and promotes the adoption of cell culture technologies. Hence, these aspects are stimulating the growth of the North America Cell Culture Market and, in turn, creating lucrative prospects for the leading companies operating in the industry.
Global Cell Culture Industry Recent Developments
Gain a Competitive Edge with Our Global Cell Culture Market Report
Frequently Asked Questions
A. The Cell Culture Market is expected to register around 11.4% CAGR during 2023-28.
A. The mounting demand for biopharmaceuticals owing to the rising prevalence of chronic diseases worldwide is the prime aspect projected to drive the Cell Culture Market during 2023-28.
A. Biospherix, Ltd., Bio-Techne Corporation, Promocell Gmbh, Eppendorf Se, Vwr International, LLC, Merck Kgaa, Becton, Dickinson & Company, Thermo Fisher Scientific, Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Himedia Laboratories, Lonza Group Ltd., and Cell Culture Company LLC are the key players operating in the Cell Culture Market.
A. Substantial costs associated with cell culture products & processes are the major growth restraints for the Cell Culture Market.
A. Biopharmaceuticals would continue generating lucrative prospects for the leading companies in the Cell Culture Market during 2023-28.
A. North America would provide profitable opportunities to the Cell Culture Market over the forecast years.
Global Cell Culture Market Research Report (2023-2028) - Table of Contents
